CN Patent

CN103585173B — 含硫酸钠和匹可硫酸的药物组合物

Assigned to Chongqing Yaoguiren Biomedical Technology Co ltd · Expires 2016-06-29 · 10y expired

What this patent protects

本发明属于药学领域，涉及到一种用于哺乳动物肠道清理的药物组合物，其特征在于该组合物含有硫酸钠2g-15g，匹可硫酸或者其药学上可接受的盐为2mg-20mg。

USPTO Abstract

本发明属于药学领域，涉及到一种用于哺乳动物肠道清理的药物组合物，其特征在于该组合物含有硫酸钠2g-15g，匹可硫酸或者其药学上可接受的盐为2mg-20mg。

Drugs covered by this patent

sodium-phosphate-dibasic-anhydrous (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS)

Patent Metadata

Patent number: CN103585173B
Jurisdiction: CN
Classification: —
Expires: 2016-06-29
Drug substance claim: No
Drug product claim: No
Assignee: Chongqing Yaoguiren Biomedical Technology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.